Clinical Trial Update: Phase I Pharmacokinetics and Safety Study of Naloxegol in Paediatric OIC Patients [Phase 1]

View source ↗

Summary

Completed Phase I pharmacokinetics and safety study of Naloxegol in pediatric patients with opioid-induced constipation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Constipation
• Opioid-induced Constipation

Drugs mentioned

• Naloxegol (naloxegol)

Snippet

Sponsor: Kyowa Kirin Pharmaceutical Development Ltd | Conditions: Constipation, Signs and Symptoms, Digestive | Phase 1 | Status: COMPLETED